Pharma major Dr Reddy’s Laboratories Ltd has launched Aripiprazole tablets, a therapeutic equivalent generic version of Abilify (aripiprazole) tablets in the US. The used to treat certain mental/mood disorders. The Abilify brand and generic tablets had US sales of approximately $3.1 billion for the most recent 12 months ended August 2016, according to IMS Health.
Dr Reddy’s sells Aripiprazole in US
Published on
October 13, 2016 17:40
Tags